That’s the actual problem here. Considering sex and age groups, the number of both complications and deaths are significantly higher than in the general population (if you accept this as control group). However, confounding factors (as far as I remember) are still present. Especially younger women already have a higher risk of sinus vene thrombosis compared to, e.g., older women and men (in general, but especially older men, again).
The rational cautious and usual choice in other circumstances is to halt vaccinations for all, the rational prudent choice is to halt vaccinations for women under (AFAIK) 35.
That said, the communication here is the actual problem. From the beginning.
This is a problem here too. Here in Brazil we know almost nothing of what is happening in other countries on the Continent. I don’t know how things are going in Colombia or Peru, for example.Some people say that we reflect our geography. We look at the Atlantic and turn our back on South America.
I can say the same for all the other BBS colleagues. I learned a lot here and I am always surprised (sometimes shocked) by the problems that are very similar in different countries.
Alternatively, my mother is the first person I know of not to get symptoms after her second shot, probably because of the immunosuppressants she takes for RA. Unfortunately, I expect that translates into inferior protection, although I have to assume that a great many people on immunosuppressants were involved in their studies of people over 65. Hell, one of my (much younger) cousins is on them.
Yes. You are right. I wish to know more about the pandemic in these continents. Some people here say that the low numbers are due to continuing use of anti malaria drugs. That old fake news.
His argument is that the pandemic in Brazil has a 2 month delay compared with Europe, e.g., the first case, the first exponential case growth, etc. happened roughly 2 months earlier in Europe.
And that is, he doesn’t offer anything else to explain his reasons, and as @BakaNeko mentions, we are already in the middle of a wave.
The most interesting parts about the interview is how the army seems to be taking the pandemics really seriously[1], but the interviewed person has to walk on eggs to avoid criticizing the president for his handling of the pandemics.
[1]: i went to one of their local ‘barracks’ because of work, and they where keeping a reasonable distance and they said that the new recruits would either do all their training by distance (no idea how) or by being interned in the quartels.
A new variant of the coronavirus has been identified in Sorocaba, a city in the state of São Paulo. According to the authorities, the new mutation of the virus is similar to that of the strain found in South Africa.
Apparently no one from that region traveled to the African continent. So the scientists believe that this is a mutation of the already known Brazilian variant. So far, only one case has been confirmed.
There are lots of perspectives and voices missing from the BBS unfortunately. There have been some Indian and African commentators. Russian and Chinese, and anybody with anything to do with either, would be fraught right now due to the current cold war. Which still leaves most of Asia and Africa as the biggest voids.
The yellow fever vaccination certificate system (already required to enter various countries) has an interesting way to solve this problem.
It is possible to get an exemption certificate, saying that a doctor believes the yellow fever vaccine is contraindicated for you. However, you can only get this certificate from a clinic that gives the vaccine, which prevents anti-vaccination or simply unscrupulous doctors setting up a sideline in exemption certificates.
Yet, accelerated production by Johnson & Johnson is critical to the Biden administration’s plans to have enough vaccine available by the end of May to immunize every adult in the country. For now, Johnson & Johnson is planning on having 100 million doses delivered by that time.
I’m not sure this is technically true in light of their Moderna and Pfizer procurements, but the JJ is certainly important for reaching people who might not be able to schedule two doses.
